Iovance Biotherapeutics Inc

NASDAQ:IOVA  
37.23
+0.72 (+1.97%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Iovance Biotherapeutics, Inc. Stock, NASDAQ:IOVA

999 Skyway Road, Suite 150, San Carlos, California 94070
United States of America
Phone: +1.650.260.7120
Number of Employees: 148

Description

Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.